相关实验视频
Updated: Jun 17, 2026

10:12
The MPLEx Protocol for Multi-omic Analyses of Soil Samples
Published on: May 30, 2018
11.6K
多omics分析确定SMPD1作为一种关键的贡献者,在2型糖尿病的发病途径为2型糖尿病的病原体
Aron Park1, Baeki E Kang2, Eun-Ju Jin3
1Department of Health Sciences and Technology, Gachon Advanced Institute for Health Sciences and Technology (GAIHST), Gachon University, Incheon, Republic of Korea.
Genes & genomics
|December 22, 2025
概括
斯芬戈米林二酶1 (SMPD1) 失调有助于2型糖尿病 (T2D) 和与代谢功能障碍相关的脂肪性肝病 (MASLD). 针对SMPD1为这些代谢障碍提供了一个有前途的治疗策略.
科学领域:
- 生物化学和分子生物学
- 代谢障碍 代谢障碍 代谢障碍
- 遗传学 是一个遗传学.
背景情况:
- 2型糖尿病 (T2D) 是一种复杂的代谢障碍,具有重大治疗挑战.
- 新出现的证据将T2D与脂代谢途径的失调联系起来.
- 脂对细胞信号传递,膜结构和代谢平衡至关重要.
研究的目的:
- 识别和描述涉及T2D病变发生的脂路的组成部分.
- 在T2D和相关的肝病症中研究基氨酸化酶1 (SMPD1) 的作用.
主要方法:
- 利用了整合基因组,转录基因组和代谢基因组数据的多omics方法.
- 使用全基因组关联研究数据进行了两样本的门德尔随机化.
- 在瘦肉和遗传/遗传小鼠中进行了体内功能验证,这些小鼠接受了重组SMPD1.1的治疗.
主要成果:
- 鉴定了SMPD1,一种将斯芬哥米林转化为陶胺的酶,作为T2D的关键因素.
- 在T2D患者中观察到脊髓蛋白减少,并确定了SMPD1表达和糖尿病特征之间的因果关系.
- 证明SMPD1在代谢功能障碍相关的脂肪性肝病 (MASLD) 肝细胞中的上调会使小鼠的葡萄糖不耐受和胰岛素耐药性恶化.
结论:
- 在T2D和MASLD中,SMPD1起着关键的致病作用.
- 对于T2D和MASLD来说,SMPD1是一个有希望的治疗标.
相关概念视频
Pathophysiology of Diabetes
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...
Type I Diabetes II: Pathophysiology
Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...
Type II Diabetes I: Introduction
Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...
Type II Diabetes II: Pathophysiology
PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
